SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 135 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2016. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $107,000 | -2.7% | 62,947 | 0.0% | 0.03% | -5.6% |
| Q2 2018 | $110,000 | -4.3% | 62,947 | 0.0% | 0.04% | -16.3% |
| Q1 2018 | $115,000 | -17.9% | 62,947 | 0.0% | 0.04% | -10.4% |
| Q4 2017 | $140,000 | -23.5% | 62,947 | 0.0% | 0.05% | -27.3% |
| Q3 2017 | $183,000 | -34.6% | 62,947 | 0.0% | 0.07% | -36.5% |
| Q2 2017 | $280,000 | -4.4% | 62,947 | 0.0% | 0.10% | -5.5% |
| Q1 2017 | $293,000 | -23.5% | 62,947 | 0.0% | 0.11% | -29.5% |
| Q4 2016 | $383,000 | +10.4% | 62,947 | 0.0% | 0.16% | +6.8% |
| Q3 2016 | $347,000 | +45.2% | 62,947 | 0.0% | 0.15% | +46.0% |
| Q2 2016 | $239,000 | +37.4% | 62,947 | 0.0% | 0.10% | +29.9% |
| Q1 2016 | $174,000 | +480.0% | 62,947 | +481.3% | 0.08% | +492.3% |
| Q3 2014 | $30,000 | -31.8% | 10,829 | 0.0% | 0.01% | -35.0% |
| Q2 2014 | $44,000 | – | 10,829 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 477,621 | $1,065,000 | 1.44% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,505,804 | $3,358,000 | 1.18% |
| Nantahala Capital Management | 7,000,000 | $15,610,000 | 0.69% |
| Hikari Power Ltd | 1,900,000 | $4,237,000 | 0.50% |
| Trellus Management Company, LLC | 112,500 | $251,000 | 0.34% |
| Cheyne Capital Management (UK) LLP | 206,500 | $462,000 | 0.20% |
| KNOTT DAVID M | 201,400 | $449,000 | 0.18% |
| Paulson & Co. | 4,000,000 | $8,920,000 | 0.17% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,041,695 | $2,323,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 318,460 | $710,000 | 0.13% |